tirzepatide fatty liver disease Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic (MASLD) Pathophysiology, noninvasive diagnostics and emerging

However, this list includes many of the symptoms

10.1038/srep16205 Sci

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), established therapies for type 2 diabetes and obesity, are increasingly recognized for their potential in neurodegenerative diseases

Nausea, mild constipation, and fatigue are the most frequent side effects and typically peak in weeks 12, then improve significantly within 24 weeks as your body adjusts

The article describes soluble fiber from sources such as oats or psyllium as working with hydration to add stool bulk and hold water in the colon, and says insoluble fiber from wheat bran and vegetables should be introduced cautiously since excess may initially increase discomfort

Without intentional food choices, people may lose muscle mass or experience nutrient deficiencies (Kolli et al